This typically works in less than 10 per cent of target cells. (newscientist.com)
The external magnetic field drives those particles into target cells. (bioprocessintl.com)
By targeting these cells with gene therapy and virtual reality stimulation, we hope to rescue them and prevent vision loss, perhaps even restore vision. (glaucoma.org)